Cargando…

Analysis of Capped Silver Nanoparticles Combined with Imipenem against Different Susceptibility Profiles of Klebsiella pneumoniae

Klebsiella pneumoniae (K. pneumoniae) is an opportunistic bacterium that has drawn attention due to its resistance to carbapenem antibiotics. The treatment of patients with severe infections has been challenging. Thus, silver nanoparticles (AgNPs) have been applied for their antimicrobial effects. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fontoura, Inglid, Veriato, Thaís S., Raniero, Leandro J., Castilho, Maiara L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044117/ https://www.ncbi.nlm.nih.gov/pubmed/36978403 http://dx.doi.org/10.3390/antibiotics12030535

Ejemplares similares

Nano-antibiotic based on silver nanoparticles functionalized to the vancomycin–cysteamine complex for treating Staphylococcus aureus and Enterococcus faecalis
por: Veriato, Thaís S., et al.
Publicado: (2023)

Activity of imipenem/relebactam on Klebsiella pneumoniae with different mechanisms of imipenem non-susceptibility
por: Mashaly, Mervat El-Sayed, et al.
Publicado: (2021)

The First Case of Septicemia Caused by Imipenem-Susceptible, Meropenem-Resistant Klebsiella pneumoniae
por: Kayama, Shizuo, et al.
Publicado: (2013)

In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase
por: Wang, Chunlei, et al.
Publicado: (2021)

IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae
por: Kubota, Hiroaki, et al.
Publicado: (2019)

Epidemiology and resistance mechanisms to imipenem in Klebsiella pneumoniae: A multicenter study
por: CHEN, HUIHONG, et al.
Publicado: (2013)

High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae
por: Wu, Ping-Feng, et al.
Publicado: (2016)

First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling
por: Tian, Xuebin, et al.
Publicado: (2020)

Cytotoxic effect of green silver nanoparticles against ampicillin-resistant Klebsiella pneumoniae
por: Hamida, Reham Samir, et al.
Publicado: (2020)

2181. Avibactam Prevents the in vitro Development of Imipenem Resistance in non-Carbapenemase-Producing Klebsiella pneumoniae
por: Quesille-Villalobos, Ana M, et al.
Publicado: (2023)

Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae
por: Mulroney, K. T., et al.
Publicado: (2017)

Imipenem represses CRISPR-Cas interference of DNA acquisition through H-NS stimulation in Klebsiella pneumoniae
por: Lin, Tzu-Lung, et al.
Publicado: (2016)

Ceftazidime–Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing Klebsiella pneumoniae
por: Ding, Li, et al.
Publicado: (2022)

Machine learning model of imipenem‐resistant Klebsiella pneumoniae based on MALDI‐TOF‐MS platform: An observational study
por: Zeng, Yu, et al.
Publicado: (2023)

Antibiofilm Effect of Biogenic Silver Nanoparticles Combined with Oregano Derivatives against Carbapenem-Resistant Klebsiella pneumoniae
por: Scandorieiro, Sara, et al.
Publicado: (2023)

Effect of Silver Nanoparticles on Biofilm Formation and EPS Production of Multidrug-Resistant Klebsiella pneumoniae
por: Siddique, Muhammad Hussnain, et al.
Publicado: (2020)

Characterization and Toxicity of Hypoxoside Capped Silver Nanoparticles
por: Badeggi, Umar M., et al.
Publicado: (2022)

Author Correction: Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae
por: Mulroney, K. T., et al.
Publicado: (2018)

In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1
por: Tang, Hung-Jen, et al.
Publicado: (2015)

Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient
por: Gaibani, Paolo, et al.
Publicado: (2022)

A Novel Approach for Combating Klebsiella pneumoniae Biofilm Using Histidine Functionalized Silver Nanoparticles
por: Chhibber, Sanjay, et al.
Publicado: (2017)

Laser-fabricated castor oil-capped silver nanoparticles
por: Zamiri, Reza, et al.
Publicado: (2011)

1583. In Vitro Activity of Imipenem/Relebactam against Klebsiella pneumoniae and Pseudomonas aeruginosa from Patients in ICUs in the Asia/Pacific region – SMART 2015-2018
por: Lob, Sibylle, et al.
Publicado: (2020)

Infection Sources and Klebsiella pneumoniae Antibiotic Susceptibilities in Endogenous Klebsiella Endophthalmitis
por: Chen, Kuan-Jen, et al.
Publicado: (2022)

No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli
por: Yayan, Josef, et al.
Publicado: (2015)

New evidence in severe pneumonia: imipenem/ cilastatin/relebactam
por: Girón, Rosa Mª, et al.
Publicado: (2022)

Biosynthesis, Characterization and Antibacterial Application of Novel Silver Nanoparticles against Drug Resistant Pathogenic Klebsiella pneumoniae and Salmonella Enteritidis
por: Huq, Md. Amdadul, et al.
Publicado: (2021)

1080. Relebactam Increases Imipenem Activity Against Imipenem-Nonsusceptible and -Susceptible Pseudomonas aeruginosa and Enterobacterales: Assessment of Isolates from RESTORE-IMI 2
por: Hilbert, David W, et al.
Publicado: (2021)

Microbial glycolipoprotein-capped silver nanoparticles as emerging antibacterial agents against cholera
por: Gahlawat, Geeta, et al.
Publicado: (2016)

2746. Assessment of in vitro synergy between Piperacillin-Tazobactam-Meropenem and Imipenem-Meropenem against OXA-48 Producing Klebsiella pneumoniae Using Time-Kill Assays
por: Demir, Mervenur, et al.
Publicado: (2023)

Biosynthesis, Characterization, and Biological Activities of Procyanidin Capped Silver Nanoparticles
por: Badeggi, Umar M., et al.
Publicado: (2020)

Transcriptome profiling in imipenem-selected Acinetobacter baumannii
por: Chang, Kai-Chih, et al.
Publicado: (2014)

High Prevalence of Ceftazidime-Resistant Klebsiella pneumoniae and Increase of Imipenem-Resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR Program in 2004
por: Lee, Kyungwon, et al.
Publicado: (2006)

Increase of Ceftazidime- and Fluoroquinolone-Resistant Klebsiella pneumoniae and Imipenem-Resistant Acinetobacter spp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007
por: Lee, Kyungwon, et al.
Publicado: (2010)

Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase
por: Bovo, Federica, et al.
Publicado: (2023)

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review
por: Zilberberg, Marya D, et al.
Publicado: (2010)

Silver Nanoparticles Induce a Triclosan-Like Antibacterial Action Mechanism in Multi-Drug Resistant Klebsiella pneumoniae
por: Pareek, Vikram, et al.
Publicado: (2021)

Vancomycin Capped with Silver Nanoparticles as an Antibacterial Agent against Multi-Drug Resistance Bacteria
por: Esmaeillou, Mahsa, et al.
Publicado: (2017)

Rifampicin conjugated silver nanoparticles: a new arena for development of antibiofilm potential against methicillin resistant Staphylococcus aureus and Klebsiella pneumoniae
por: Farooq, Umar, et al.
Publicado: (2019)

Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance
por: Lee, Kyungwon, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_lth8hc9oh39nhdhh515qofh21t